IBA is a leader in proton therapy, having sold 18 proton therapy systems worldwide. A form of radiotherapy, proton therapy delivers a precise dose of protons to a tumor to kill cancer cells while sparing healthy surrounding tissue. IBA is now entering into new treatment techniques such as carbon therapy, a more powerful and precise method to treat tumors, in particular ones which show resistance to radiology treatments. Higher doses can be delivered to the tumor without increasing the risk of side effects and long term complications, thereby minimizing the number of treatment sessions needed and improving treatment results and patient quality of life.
About IBA
Ad Statistics
Times Displayed: 50094
Times Visited: 1414 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
IBA develops and markets leading-edge technologies, pharmaceuticals and tailor-made solutions for healthcare with a focus on cancer diagnosis and therapy. Leveraging on its scientific expertise, IBA is also active in the field of industrial sterilization and ionization.
Listed on the pan-European stock exchange EURONEXT, IBA is included in the BelMid Index.
(IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).
Website: http://www.iba-worldwide.com
Back to HCB News
